Insys Therapeutics, Inc.
Case Number:
1:19-bk-11292
Court:
Nature of Suit:
Firms
- Akin Gump
- ASK LLP
- Barrett Law Group
- Benesch
- Berger Harris
- Bielli & Klauder
- Blank Rome
- Bonville & Howard
- Brown Rudnick
- Buchanan Ingersoll
- Chamberlain Hrdlicka
- Chiesa Shahinian
- Chipman Brown
- Cole Schotz
- Connolly Gallagher
- Consovoy McCarthy
- Cross & Simon
- Duane Morris
- Eckert Seamans
- Faegre Drinker
- Ferry Joseph
- Gellert Scali
- Gilbert LLP
- Hagens Berman
- Halperin Battaglia
- Hogan McDaniel
- Holland & Knight
- Howard & Howard
- Hughes Hubbard
- Hutchison & Steffen
- Keller Postman
- Klehr Harrison
- Landis Rath
- Lowenstein Sandler
- Mayer Brown
- May Potenza
- McCarter & English
- McDermott Will & Emery
- Montgomery McCracken
- Morris Nichols
- Orlans PC
- Pachulski Stang
- Patterson Belknap
- Pillsbury Winthrop
- Potter Anderson
- Reid Collins
- Richards Layton
- Robins Kaplan
- Rosner Law Group LLC
- Seward & Kissel
- Shipman & Goodwin
- Sills Cummis
- Skadden Arps
- Stevens & Lee
- Stoel Rives
- Sullivan Hazeltine
- Theodora Oringher
- Wagstaff & Cartmell
- Weil Gotshal
- Wilson Sonsini
- Womble Bond
- Young Conaway
Companies
- Bessemer Group Inc.
- Cardinal Health Inc.
- Cencora Inc.
- Covance Inc.
- Ernst & Young LLP
- FTI Consulting Inc.
- H.D. Smith LLC
- Iron Mountain Inc.
- Ironshore Inc.
- Johnson & Johnson
- Lazard Ltd.
- McKesson Corp.
- Pioneer Telephone Cooperative Inc.
- Receptor Life Sciences
- Salt River Project
- The Children's Hospital of Philadelphia
- The Cigna Group
- Toyota Motor Corp.
Government Agencies
- California Department of Health Care Services
- Commonwealth of Kentucky
- Missouri Department of Revenue
- New York State Department of Health
- Pennsylvania Department of Human Services
- State of Indiana
- State of Michigan
- State of Nevada
- Texas Comptroller of Public Accounts
Sectors & Industries:
-
June 17, 2019
Insys Hit With Nationwide Opioid Class Claim In Ch. 11
Bankrupt Insys Therapeutics was hit Monday with a motion seeking recognition of a proposed nationwide class of privately insured consumers, who say the "scourge of opioid abuse" unleashed by the opioid maker jacked up their premiums.
- ← Previous
- 1
- 2
- 3
- 4
- Next →